Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. In recent years, microRNAs have gained significant attention for their potential role in pharmacology and drug development. They are involved in various biological processes, including cell differentiation, proliferation, apoptosis, and inflammation, and have been implicated in several diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders. This article reviews the role of microRNAs in drug development, focusing on their potential as therapeutic targets and biomarkers, their involvement in drug resistance, and their application in personalized medicine.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.